Ultrafiltration is Associated With Fewer Rehospitalizations than Continuous Diuretic Infusion in Patients With Decompensated Heart Failure: Results From UNLOAD

被引:104
|
作者
Costanzo, Maria Rosa [1 ]
Saltzberg, Mitchell T. [2 ]
Jessup, Mariell
Teerlink, John R. [3 ]
Sobotka, Paul A. [4 ]
机构
[1] Midwest Heart Fdn, Lombard, IL USA
[2] Univ Penn, Dept Med, Div Cardiol, Christiana Hosp, Philadelphia, PA 19104 USA
[3] Univ Calif San Francisco, Cardiol Sect, San Francisco Vet Affairs Med Ctr, Sch Med, San Francisco, CA 94143 USA
[4] Ohio State Univ, Affiliate Fac, Columbus, OH 43210 USA
关键词
Ultrafiltration; diuretics; heart failure; BODY-FLUID; FUROSEMIDE; RESISTANCE; OUTCOMES; REGISTRY; TRIAL; DEATH;
D O I
10.1016/j.cardfail.2009.12.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Compare outcomes of ultrafiltration (UF) versus standard intravenous (IV) diuretics by continuous infusion or bolus injection in volume overloaded heart failure (HF) patients. In the Ultrafiltration versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated heart Failure (UNLOAD) study, UF produced greater fluid reduction and fewer HF rehospitalizations than IV diuretics in 200 hospitalized HF patients. Outcomes may be due to greater fluid removal, but UF removes more sodium/unit volume than diuretics. Methods and Results: Outcomes of 100 patients randomized to UF were compared with those of patients randomized to standard IV diuretic therapy with continuous infusion (32) or bolus injections (68). Choice of diuretic therapy was by the treating physician. Forty-eight hour weight loss (kg): 5.0 +/- 3.1 UF, 3.6 +/- 3.5 continuous infusion, and 2.9 +/- 3.5 bolus diuretics (P = .001 UF versus bolus diuretic; P > .05 for the other comparisons). Net fluid loss (L): 4.6 +/- 2.6 UF, 3.9 +/- 2.7 continuous infusion, and 3.1 +/- 2.6 bolus diuretics (P < .001 UF versus bolus diuretic; P > .05 for the other comparisons). At 90 days, rehospitalizations plus unscheduled visits for HF/patient (rehospitalization equivalents) were fewer in UF group (0.65 +/- 1.36) than in continuous infusion (2.29 +/- 3.23; P = .016 versus UF) and bolus diuretics (1.31 +/- 1.87; P = .050 versus UF) groups. No serum creatinine differences occurred between groups up to 90 days. Conclusions: Despite similar fluid loss with UF and continuous diuretic infusion, fewer HF rehospitalizations equivalents occurred only with UF. Removal of isotonic fluid by UF compared with hypotonic urine by diuretics more effectively reduces total body sodium in congested HE patients. (J Cardiac Fail 2010;16:277-284)
引用
收藏
页码:277 / 284
页数:8
相关论文
共 40 条
  • [31] Prescription, Compliance, and Burden Associated with Salt-Restricted Diets in Heart Failure Patients: Results from the French National OFICSel Observatory
    Damy, Thibaud
    Benedyga, Veronique
    Pezel, Theo
    Berthelot, Emmanuelle
    Gauthier, Jacques
    Habib, Gilbert
    Iliou, Marie-Christine
    Aupetit, Jean-Francois
    Baudry, Guillaume
    De Groote, Pascal
    Logeart, Damien
    Chaufourier, Laure
    Ciobotaru, Vlad
    Pousset, Francoise
    Beauvais, Florence
    Bauer, Fabrice
    Zores, Florian
    Lairez, Olivier
    Richard, Kevin
    Hittinger, Luc
    Teiger, Emmanuel
    Taieb, Charles
    Audureau, Etienne
    NUTRIENTS, 2022, 14 (02)
  • [32] Elevated Resting Heart Rate is Associated With Impaired Quality of Life and Worse NYHA Functional Capacity in Patients With Chronic Heart Failure: Results From REALITY HF Study
    Cavusoglu, Yuksel
    Kozan, Omer
    Temizhan, Ahmet
    Kucukoglu, Serdar
    CIRCULATION, 2014, 130
  • [33] Factors and Outcomes Associated With Improving Left Ventricular Systolic Function in Patients With Cardiomyopathy: Results From the Sudden Cardiac Death in Heart Failure Trial
    Eiger, Dylan S.
    Inoue, Lurdes Y.
    Bardy, Gust
    Lee, Kerry
    Poole, Jeanne
    Mark, Daniel B.
    Samad, Zainab
    Friedman, Daniel J.
    Overton, Robert
    Sanders, Gillian D.
    Al-Khatib, Sana M.
    CIRCULATION, 2018, 138
  • [34] The Incidence and Risk Associated with a Serum Potassium <4.0 Mmol/l in Patients with Heart Failure and a Reduced Left Ventricular Ejection Fraction (HF-REF): Results from the Emphasis-HF Trial
    Pitt, Bertram
    McMurray, John J.
    Swedberg, Karl
    Pocock, Stuart
    Krum, Henry
    van Veldhuisen, Dirk J.
    Shi, Harry
    Vincent, John
    Zannad, Faiez
    CIRCULATION, 2012, 126 (21)
  • [35] Severe Obesity, but not Overweight, is Associated With Short-and Long-term Decreased Mortality in Patients With Type 2 Diabetes Hospitalized for Acute Decompensated Heart Failure: Findings From the Gulf-care
    Khalil, Charbel Abi
    Suleiman, Kadhim
    Singh, Rajvir
    Asaad, Nidal
    Jayyousi, Amin
    Al Suwaidi, Jassim
    CIRCULATION, 2016, 134
  • [36] Factors associated with general practitioners’ awareness of depression in primary care patients with heart failure: baseline-results from the observational RECODE-HF study
    Marion Eisele
    Anja Rakebrandt
    Sigrid Boczor
    Agata Kazek
    Nadine Pohontsch
    Magdalena Okolo-Kulak
    Eva Blozik
    Jens-Martin Träder
    Stefan Störk
    Christoph Herrmann-Lingen
    Martin Scherer
    BMC Family Practice, 18
  • [37] Factors associated with general practitioners' awareness of depression in primary care patients with heart failure: baseline-results from the observational RECODE-HF study
    Eisele, Marion
    Rakebrandt, Anja
    Boczor, Sigrid
    Kazek, Agata
    Pohontsch, Nadine
    Okolo-Kulak, Magdalena
    Blozik, Eva
    Traeder, Jens-Martin
    Stoerk, Stefan
    Herrmann-Lingen, Christoph
    Scherer, Martin
    BMC FAMILY PRACTICE, 2017, 18
  • [38] Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure -: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study
    Klein, L
    O'Connor, CM
    Leimberger, JD
    Gattis-Stough, W
    Piña, IL
    Felker, M
    Adams, KF
    Califf, RM
    Gheorghiade, M
    CIRCULATION, 2005, 111 (19) : 2454 - 2460
  • [39] Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme
    Johansson, Isabelle
    Balasubramanian, Kumar
    Bangdiwala, Shrikant
    Mielniczuk, Lisa
    Hage, Camilla
    Sharma, Sanjib Kumar
    Branch, Kelley
    Zhu, Jun
    Kragholm, Kristian
    Sliwa, Karen
    Alla, Francois
    Yonga, Gerald
    Roy, Ambuj
    Orlandini, Andres
    Grinvalds, Alex
    McCready, Tara
    Pogosova, Nana
    Stoerk, Stefan
    McMurray, John J. V.
    Conen, David
    Yusuf, Salim
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1478 - 1490
  • [40] Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study
    Langslet, Gisle
    Nystroem, Thomas
    Vistisen, Dorte
    Carstensen, Bendix
    Grip, Emilie Toresson
    Casajust, Paula
    Tskhvarashvili, Giorgi
    Hoti, Fabian
    Klement, Riho
    Karlsdotter, Kristina
    Tuovinen, Mikko
    Ofstad, Anne Pernille
    Lajer, Maria
    Shay, Christina
    Koeneman, Lisette
    Farsani, Soulmaz Fazeli
    Niskanen, Leo
    Halvorsen, Sigrun
    JOURNAL OF DIABETES RESEARCH, 2024, 2024